Profil
Rodolfo Cesar Bellinzoni has held positions as Vice Chairman at Yangling Jinhai Biotechnology Co., Ltd.
since 2017 and Chief Operating Director at Biogenesis Bago SA.
Aktive Positionen von Rodolfo Cesar Bellinzoni
| Unternehmen | Position | Beginn |
|---|---|---|
Biogenesis Bago SA
 Biogenesis Bago SA Pharmaceuticals: MajorHealth Technology Biogenesis Bago SA is a biotechnology company. It is engaged in investigation, developing, manufacturing and marketing of biotechnological products and providing veterinary services to improve livestock health and productivity. The company was founded in 1934 and is headquartered in Buenos Aires, Argentina. | Geschäftsführer | - |
Yangling Jinhai Biotechnology Co., Ltd.
 Yangling Jinhai Biotechnology Co., Ltd. BiotechnologyHealth Technology Yangling Jinhai Biotechnology Co., Ltd. is a company based in Xianyang, China. The Chinese company specializes in biotechnology and offers a range of products, including a vaccine for foot-and-mouth disease in pigs. The company was founded in 2013, and the CEO is Hai Ming Zhang. | Direktor/Vorstandsmitglied | 22.01.2017 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Biogenesis Bago SA
Biogenesis Bago SA Pharmaceuticals: MajorHealth Technology Biogenesis Bago SA is a biotechnology company. It is engaged in investigation, developing, manufacturing and marketing of biotechnological products and providing veterinary services to improve livestock health and productivity. The company was founded in 1934 and is headquartered in Buenos Aires, Argentina. | Health Technology |
Yangling Jinhai Biotechnology Co., Ltd.
Yangling Jinhai Biotechnology Co., Ltd. BiotechnologyHealth Technology Yangling Jinhai Biotechnology Co., Ltd. is a company based in Xianyang, China. The Chinese company specializes in biotechnology and offers a range of products, including a vaccine for foot-and-mouth disease in pigs. The company was founded in 2013, and the CEO is Hai Ming Zhang. | Health Technology |
